Cells talk to each other by releasing small membrane-wrapped packages called extracellular vesicles. Exosomes are the smallest of these, in the range of tens of nanometers, and they carry proteins, lipids, messenger RNA and microRNA from the cell that made them. When one is taken up by another cell, that cargo can change what the receiving cell does — including turning on repair and collagen-building programs in fibroblasts.
That is the theory behind exosome skincare. If you could deliver exosomes from a young, active cell type into aging skin, you might get the signaling benefit of a stem cell treatment without transplanting any cells. It is a coherent idea and there is real laboratory science underneath it.
Three things get in the way in practice.
The first is delivery. Intact skin is designed to keep things out, and the practical limit for passive penetration is molecules of a few hundred daltons. An exosome is a lipid-membrane package tens of nanometers across — thousands of times larger. Intact exosomes applied to healthy skin almost certainly do not reach the living layers. Any effect a serum has on unbroken skin is coming from the other things in the formula: peptides, growth factors, humectants and the base itself. This is why the products are pushed so hard as a post-microneedling add-on, where the barrier has been physically breached.
The second is what is actually in the bottle. Exosomes are fragile. They need careful isolation, cold storage and gentle handling, and there is no standardized potency test that a buyer can check. A vial may contain intact exosomes, broken vesicle fragments, the conditioned media the cells were grown in, or essentially nothing biologically active. Nobody outside the manufacturer can tell you which, and labeled particle counts are not comparable between brands.
The third is source. Products are made from human mesenchymal stem cells taken from fat, bone marrow or umbilical cord tissue; from platelets; from plants; and, in some marketed products, from salmon. These are not equivalent things, and "exosome" on a box describes a category, not a defined ingredient.
Applied to intact skin, most topical exosome serums are uneventful — which is consistent with very little getting through. The risks concentrate around applying an unregulated biological product into skin that has been opened.
Anyone being offered exosomes as an injection, in the United States, should decline. No exosome product is FDA-approved for injection, the agency has warned publicly about unapproved exosome products, and serious infections have followed their use. This is the clearest line on this page.
Anyone with active infection, active acne with inflamed lesions, or a healing wound in the area should not have anything applied into breached skin.
Anyone with a history of keloids or granulomatous reactions to injected or implanted material should be cautious about introducing an unregulated biological product into the dermis.
Pregnancy and breastfeeding: skip it. Not because harm is known, but because the composition is unverified and there is no reason to take an unquantified exposure for a cosmetic benefit that is itself unproven.
People with cancer, active autoimmune disease or on immunosuppressive treatment should discuss it with their own specialist first. Products intended to stimulate cell signaling in tissue have not been studied in these groups.
If you object to human-derived biological material — many of these products come from donated human tissue, including umbilical cord — ask about the source. Clinics do not always volunteer it.
And if you are choosing between this and a treatment with real evidence, and your budget only stretches to one, this is not the one.
Honestly: it may not, and the timelines being quoted are marketing rather than data.
Days after a procedure. Skin looks fresher and calmer, and this is genuinely how post-procedure skin behaves with good aftercare. It is very hard to attribute to the serum rather than to the microneedling, the occlusion or the moisturizer.
Four to twelve weeks. Any real improvement in texture and fine lines after a course of microneedling or laser appears in this window — driven by the collagen response to the procedure itself, which happens whether or not anything was painted on afterwards.
Three to six months for hair. This is the timeline claimed for scalp products, and it is also the timeline over which hair naturally fluctuates and over which minoxidil works. Without a comparison it is essentially impossible to attribute.
Topical serum on intact skin. There is no reliable timeline because there is no reliable evidence of an exosome-specific effect. If the formula suits your skin you may like it within a few weeks, for the same reasons you might like any good serum.
When you stop. Nothing rebounds. Whatever benefit came from the procedure remains on its own schedule, and gradual loss of collagen resumes as it always does.
The state of the evidence, said plainly. Most of what exists is laboratory work, small case series and studies run or funded by the companies selling the products. There are no large independent trials establishing that a topical exosome product outperforms an equivalent well-formulated serum. That may change — the field is moving — but as things stand, this is an interesting technology being sold well ahead of its evidence.